IN2014DN03429A - - Google Patents
Info
- Publication number
- IN2014DN03429A IN2014DN03429A IN3429DEN2014A IN2014DN03429A IN 2014DN03429 A IN2014DN03429 A IN 2014DN03429A IN 3429DEN2014 A IN3429DEN2014 A IN 3429DEN2014A IN 2014DN03429 A IN2014DN03429 A IN 2014DN03429A
- Authority
- IN
- India
- Prior art keywords
- inhibitor
- matrix
- allergene
- whereon
- adsorbed
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 abstract 4
- 239000011159 matrix material Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11075261.5A EP2596802A1 (en) | 2011-11-23 | 2011-11-23 | Pharmaceutical composition for treatment of allergic reactions |
| PCT/EP2012/004884 WO2013075846A1 (en) | 2011-11-23 | 2012-11-23 | Pharmaceutical composition for treatment of allergic reactions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN03429A true IN2014DN03429A (https=) | 2015-06-05 |
Family
ID=47358079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3429DEN2014 IN2014DN03429A (https=) | 2011-11-23 | 2012-11-23 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20140335162A1 (https=) |
| EP (1) | EP2596802A1 (https=) |
| CN (1) | CN104039349A (https=) |
| BR (1) | BR112014012277A2 (https=) |
| IN (1) | IN2014DN03429A (https=) |
| WO (1) | WO2013075846A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2813242A1 (en) * | 2013-06-13 | 2014-12-17 | PLS-Design GmbH | Low molecular weight immune-modulators as adjuvants for specific immunotherapy |
| EP2918262B1 (en) * | 2014-03-10 | 2023-08-09 | PLS-Design GmbH | Induction of antigen-specific tolerance by peripheral phagocytosis |
| SG11201705064XA (en) * | 2014-12-24 | 2017-07-28 | Neximmune Inc | Nanoparticle compositions and methods for immunotherapy |
| CN105727371B (zh) * | 2016-01-25 | 2019-04-09 | 北京天助畅运医疗技术股份有限公司 | 腹壁疝修补材料 |
| KR102460040B1 (ko) | 2016-04-27 | 2022-11-01 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| CN107669638B (zh) * | 2017-10-23 | 2020-05-22 | 华南理工大学 | 一种peg-pcl-peg三嵌段共聚物修饰的羟基积雪草苷脂质体及其应用 |
| BR112022021204A2 (pt) * | 2020-04-22 | 2022-12-06 | Kindred Biosciences Inc | Polipeptídeos, proteínas heterodiméricas, ácido nucleico, células hospedeiras, método, composição farmacêutica e método de tratamento de uma espécie de animal de companhia, métodos para reduzir a atividade de sinalização de il13 e/ou il4 e para detectar il13 ou il4 em uma amostra |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| US5126147A (en) * | 1990-02-08 | 1992-06-30 | Biosearch, Inc. | Sustained release dosage form |
| DE4137333A1 (de) | 1991-11-13 | 1993-05-19 | W Prof Dr Sebald | Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung |
| BR9709715A (pt) | 1996-06-14 | 1999-08-10 | Bayer Ag | Agonistas de interleucina-4 seletivos para células t |
| US6028176A (en) | 1996-07-19 | 2000-02-22 | Bayer Corporation | High-affinity interleukin-4 muteins |
| CA2305621C (en) | 1997-10-03 | 2009-01-20 | Macromed, Inc. | Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| RU2225197C2 (ru) * | 1998-03-02 | 2004-03-10 | Эпплайд Вэксин Текнолоджиз Корп. | Способы и устройства для модуляции иммунного ответа |
| IL138207A0 (en) * | 1998-03-02 | 2001-10-31 | Applied Vaccine Technologies C | Methods and devices for modulating the immune response |
| US6841617B2 (en) * | 2000-09-28 | 2005-01-11 | Battelle Memorial Institute | Thermogelling biodegradable aqueous polymer solution |
| US6451346B1 (en) * | 1998-12-23 | 2002-09-17 | Amgen Inc | Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents |
| AU4139801A (en) * | 1999-12-06 | 2001-06-12 | Board Of Trustees Of The University Of Arkansas, The | Controlled delivery of antigens |
| EP2990420B1 (en) | 2000-05-26 | 2016-12-21 | Immunex Corporation | Use of interleukin-4 receptor antibodies and compositions thereof |
| AU2001273413A1 (en) | 2000-07-12 | 2002-01-21 | Immunex Corporation | Method for treating cancer using an interleukin- 4 antagonist |
| US20030003074A1 (en) | 2001-06-14 | 2003-01-02 | Macromed, Inc. | Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| ATE378427T1 (de) | 2005-10-17 | 2007-11-15 | Rina Netzwerk Rna Technologien | Verfahren zur bestimmung einer unbekannten pns seqenz und seine verwendungen |
| MX2008008968A (es) * | 2006-01-11 | 2008-09-10 | Aerovance Inc | Metodos y composiciones para tratar asma en primates humanos y no humanos. |
| EP2630966B1 (en) * | 2007-10-12 | 2017-04-19 | Massachusetts Institute of Technology | Vaccine nanotechnology |
| BRPI0822099A2 (pt) | 2007-12-21 | 2017-05-23 | Medimmune Ltd | membro de ligação isolado, uso de um membro de ligação isolado, método parav tratar um distúrbio, molécula de ácido nucléico isolada, célula hospedeira, e, método para produzir um membro de ligação |
| PE20110943A1 (es) * | 2009-01-28 | 2012-01-22 | Novartis Ag | Formulacion oral solida de alisquireno |
| JP5656370B2 (ja) | 2009-07-01 | 2015-01-21 | キヤノン株式会社 | 画像処理装置、画像処理システム、画像処理方法、およびプログラム |
-
2011
- 2011-11-23 EP EP11075261.5A patent/EP2596802A1/en not_active Withdrawn
-
2012
- 2012-11-23 US US14/360,343 patent/US20140335162A1/en not_active Abandoned
- 2012-11-23 IN IN3429DEN2014 patent/IN2014DN03429A/en unknown
- 2012-11-23 CN CN201280057730.4A patent/CN104039349A/zh active Pending
- 2012-11-23 BR BR112014012277A patent/BR112014012277A2/pt not_active IP Right Cessation
- 2012-11-23 WO PCT/EP2012/004884 patent/WO2013075846A1/en not_active Ceased
-
2017
- 2017-11-06 US US15/804,532 patent/US20180117143A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20180117143A1 (en) | 2018-05-03 |
| BR112014012277A2 (pt) | 2019-09-24 |
| EP2596802A1 (en) | 2013-05-29 |
| US20140335162A1 (en) | 2014-11-13 |
| CN104039349A (zh) | 2014-09-10 |
| WO2013075846A1 (en) | 2013-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN03429A (https=) | ||
| PH12013501842A1 (en) | Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor | |
| PH12012502161A1 (en) | Pharmaceutical formulations comprising pioglitazone and linagliptin | |
| CO6771409A2 (es) | Acidos 1-bencilcicloalquilcarboxilicos sustituidos y su uso | |
| IN2014DN06501A (https=) | ||
| PH12017501306A1 (en) | Inhibitors of histone demethylases | |
| PH12012500632B1 (en) | Pharmaceutical compositions comprising bi-1356 and metformin | |
| EP3354640A3 (en) | Mif inhibitors and their uses | |
| PH12012502162A1 (en) | Combination therapy | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| BR112012032816A2 (pt) | composição farmacêutica de liberação controlada, e, métodos para reduzir o efeito alimentar de uma composição de liberação controlada, reduzir o período de tempo necessário para que seja alcançado um estado estável para a metformina, para aperfeiçoar a biodisponibilidade de uma forma de dosagem de liberação controlada de matriz | |
| EA201101190A1 (ru) | Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение | |
| UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
| MX345777B (es) | Formulaciones de tabletas bicapa. | |
| GB2503066B (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| TN2011000471A1 (en) | Pharmaceutical composition presenting anti-inflammatory properties | |
| BR112015011430A2 (pt) | composição para liberação imediata e prolongada | |
| UY33530A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias | |
| GB2497453B8 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| CL2013001482A1 (es) | Compuestos derivados de 3-metil-7-oxo-4-tia-1-aza-biciclo[3.2.0]heptano para utilizarse en la inhibicion de beta-lactamasas producidas por bacterias y restaurar/potenciar la actividad de antibioticos; y composicion farmaceutica que los comprende. | |
| CL2012003265A1 (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo. | |
| PH12013501896A1 (en) | Use of a sprayable composition comprising ambroxol | |
| CL2010000899A1 (es) | N1-bencil-n8-hidroxi octanodiamida; composicion farmaceutica que comprende a dicho compuesto; combinacion farmaceutica que comprende a dicho compuesto; y su uso en el tratamiento de tumores.(divisional de la solicitud 1247-04). | |
| GEP201706680B (en) | Catechol o-methyltransferase activity inhibiting compounds | |
| SA515360233B1 (ar) | مثبطات إنزيمات هستون ديميثيلاز |